TAC/ALP campaign to get Bristol-Myers Squibb to reduce the price of amphotericin B
TAC and the AIDS Law Project (ALP) have successfully campaigned for
Bristol-Myers Squibb (BMS) to reduce the price of amphotericin B
R22.60 per vial in both the private and public sectors, effective 1
July 2005. This price excludes VAT (14%) and logistical costs in the
private sector (at most 10%).
Below is the correspondence between the ALP and BMS which
resulted in this price reduction: